BusinessWednesday, August 5, 2026· 2 min read

Google Elevates Demis Hassabis to Guide Alphabet’s Next AI Breakthroughs

Source: The Verge AI

TL;DR

Google is reshaping its AI leadership, naming DeepMind’s Demis Hassabis as chair of Google DeepMind and chief scientist at Alphabet. The move could sharpen Alphabet’s long-term AI research strategy while keeping health-focused AI, including drug discovery work at Isomorphic Labs, at the center of its ambitions.

Key Takeaways

  • 1Demis Hassabis will become chair of Google DeepMind and chief scientist at Alphabet.
  • 2Koray Kavukcuoglu, formerly DeepMind’s CTO, is stepping up as SVP of DeepMind while remaining Google’s chief AI architect.
  • 3Hassabis will continue leading Isomorphic Labs, Alphabet’s AI-driven drug discovery company.
  • 4The leadership shift signals Google’s continued investment in frontier AI research and real-world applications.

Google is making a major update to its AI leadership structure, elevating DeepMind cofounder Demis Hassabis into a broader scientific role across Alphabet. Hassabis will become chair of Google DeepMind and chief scientist at Alphabet, positioning him to help guide the company’s long-term AI research agenda.

The change also brings new operational leadership to DeepMind. Koray Kavukcuoglu, previously DeepMind’s CTO, will become Google’s SVP of DeepMind and continue serving as Google’s chief AI architect, giving the organization a leader deeply involved in its technical direction.

Why this matters

This is a positive signal for AI progress because it puts one of the field’s most influential researchers in a role focused on scientific ambition across Alphabet. Hassabis has repeatedly emphasized AI’s potential to improve human health, and he will continue leading Isomorphic Labs, which applies AI to drug discovery.

  • Stronger research focus: Alphabet is giving AI science a more prominent seat at the top.
  • Continuity at DeepMind: Kavukcuoglu’s promotion keeps technical leadership close to the lab’s core work.
  • Health impact potential: Continued support for Isomorphic Labs could accelerate AI-assisted medicine.

While this is an organizational move rather than a new product launch, it could influence the direction of some of the world’s most important AI research. For Google and Alphabet, the message is clear: frontier AI and its practical benefits remain central to the company’s future.

Get AI Wins in Your Inbox

The best positive AI stories delivered to your inbox. No spam, unsubscribe anytime.